Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial)

Benutzer: Gast

Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Mazer, C David ; Siadati-Fini, Niloufar ; Boehm, Johannes ; Wirth, Felix ; Myjavec, Andrej ; Brown, Craig D ; Koyner, Jay L ; Boening, Andreas ; Engelman, Daniel T ; Larsson, Tobias E ; Renfurm, Ronny ; de Varennes, Benoit ; Noiseux, Nicolas ; Thielmann, Matthias ; Lamy, Andre ; Laflamme, Maxime ; von Groote, Thilo ; Ronco, Claudio ; Zarbock, Alexander
Titel:: Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial)
Stichworte:: Anaesthesia ; Cardiac surgery ; Acute renal failure ; Adult intensive & critical care
Zeitschriftentitel:: BMJ Open
Jahr:: 2023
Band / Volume:: 13
Heft / Issue:: 4
Volltext / DOI:: doi:10.1136/bmjopen-2022-068363
Verlag / Institution:: British Medical Journal Publishing Group
E-ISSN:: 2044-6055
Publikationsdatum:: 06.04.2023
BibTeX

Vorkommen: